LDLR and atherosclerosis: In both the atherosclerosis-prone ApoE-/- and Ldlr-/- mice, the activation of FXR with a synthetic agonist inhibits the diet-induced increase in non-HDL-C and triglyceridemia and determines a near complete inhibition of aortic lesion formation [221].